METROSIN XL AM 50 TABLET

Product Description

METROSIN XL AM 50 TABLET Dual Action Extended-Release Therapy for Comprehensive Blood Pressure Control

METROSIN XL AM 50 TABLET combines Metoprolol Succinate 47.5 mg (equivalent to Metoprolol Tartrate ER 50 mg) with Amlodipine Besylate (equivalent to Amlodipine 5 mg), offering a powerful once-daily treatment for hypertension and cardiovascular risk reduction. This combination of a beta-blocker and calcium channel blocker provides synergistic blood pressure control and heart protection.

Key Benefits:

• Dual mechanism for more effective blood pressure management

• Metoprolol (ER) helps lower heart rate and blood pressure with long-lasting control

• Amlodipine relaxes blood vessels, reducing vascular resistance and chest pain

• Reduces the risk of heart attack, stroke, and other cardiovascular complications

• Ideal for patients requiring combination therapy for hypertension or angina

Recommended Usage:

Formulated for patients with moderate to severe hypertension, stable angina, and post-cardiac event care. Preferred by cardiologists and general practitioners for its once-daily convenience and therapeutic effectiveness.

Why Choose METROSIN XL AM 50?

Manufactured with high-quality standards, METROSIN XL AM 50 is a clinically trusted cardiovascular solution for long-term therapy. An essential addition for pharma distributors, hospital procurement teams, and bulk medicine buyers looking to offer high-demand chronic care medications.

Strengthen your product portfolio with METROSIN XL AM 50 TABLET a reliable, dual-action solution for modern heart health management. Contact us today for bulk orders and distribution opportunities.